Eli Lilly and Co. will gain full ownership of the impotence treatment Cialis with a $2.1 billion acquisition of joint venture partner Icos Corp., the companies announced Tuesday. Lilly will pay $32 ...

Icos Corp., the largest publicly traded biotechnology company in the Seattle area and the developer of the erectile dysfunction drug Cialis, has agreed to be acquired for $2.1 billion in cash by its ...

After an acrimonious three-month takeover battle, it took barely 12 minutes Thursday to bring the curtain down on Bothell-based Icos. Investors holding about two-thirds of Icos’ stock voted to sell ...

Eli Lilly & Co. bumped up its offer for Bothell's Icos Corp. on Monday by 6 percent after a proxy firm and others advised shareholders to vote against an earlier offer. Lilly originally offered $32 ...